JoLyn Turner

504 total citations
9 papers, 390 citations indexed

About

JoLyn Turner is a scholar working on Oncology, Molecular Biology and Nephrology. According to data from OpenAlex, JoLyn Turner has authored 9 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Molecular Biology and 2 papers in Nephrology. Recurrent topics in JoLyn Turner's work include Liver Disease Diagnosis and Treatment (2 papers), Hepatitis C virus research (2 papers) and Chronic Kidney Disease and Diabetes (2 papers). JoLyn Turner is often cited by papers focused on Liver Disease Diagnosis and Treatment (2 papers), Hepatitis C virus research (2 papers) and Chronic Kidney Disease and Diabetes (2 papers). JoLyn Turner collaborates with scholars based in United States and Israel. JoLyn Turner's co-authors include Frank M. Torti, Suzy V. Torti, Bryan T. Greene, Joan L. Buss, Barry I. Freedman, Jasmin Divers, Mariana Murea, Marina Núñez, Carl D. Langefeld and Andrew A. Hicks and has published in prestigious journals such as Blood, Kidney International and Nephrology Dialysis Transplantation.

In The Last Decade

JoLyn Turner

9 papers receiving 388 citations

Peers

Countries citing papers authored by JoLyn Turner

Since Specialization

Citations

This map shows the geographic impact of JoLyn Turner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JoLyn Turner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JoLyn Turner more than expected).

Fields of papers citing papers by JoLyn Turner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by JoLyn Turner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JoLyn Turner. The network helps show where JoLyn Turner may publish in the future.

Co-authorship network of co-authors of JoLyn Turner

This figure shows the co-authorship network connecting the top 25 collaborators of JoLyn Turner. A scholar is included among the top collaborators of JoLyn Turner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with JoLyn Turner. JoLyn Turner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	A Novel Metastatic Estrogen Receptor-Expressing Breast Cancer Model with Antiestrogen Responsiveness 2023 ·Cancers ·(unknown), Lihong Shi, Adam S. Wilson, (unknown), Brian Westwood, (unknown), (unknown), (unknown), JoLyn Turner, Carl D. Langefeld, Ravi Singh, Katherine L. Cook, Bethany A. Kerr	2
2	JC polyoma viruria associates with protection from chronic kidney disease independently from apolipoprotein L1 genotype in African Americans 2017 ·Nephrology Dialysis Transplantation ·Barry I. Freedman, Amy Kistler, Peter Skewes-Cox, Don Ganem, Mitzie Spainhour, JoLyn Turner, Jasmin Divers, Carl D. Langefeld, Mariana Murea, Andrew A. Hicks, Ashok K. Hemal, James A. Snipes, Lihong Zhao, Johanna R. Abend, Douglas S. Lyles, Lijun Ma, Karl Skorecki	13
3	Hepatic peroxisome proliferator-activated receptor γ and α-mRNA expression in HCV-infected adults is decreased by HIV co-infection and is also affected by ethnicity 2015 ·Clinics ·Nathan J. Shores, Maria Cássia Mendes-Corrêa, Ivana Maida, JoLyn Turner, Kevin P. High, Sergio Babudieri, Marina Núñez	5
4	JC polyoma virus interacts with APOL1 in African Americans with nondiabetic nephropathy 2013 ·Kidney International ·Jasmin Divers, Marina Núñez, Kevin P. High, Mariana Murea, Michael V. Rocco, Lijun Ma, Donald W. Bowden, Andrew A. Hicks, Mitzie Spainhour, David A. Ornelles, Steven B. Kleiboeker, (unknown), Carl D. Langefeld, JoLyn Turner, Barry I. Freedman	46
5	Association of APOL1 variants with mild kidney disease in the first-degree relatives of African American patients with non-diabetic end-stage renal disease 2012 ·Kidney International ·Barry I. Freedman, Carl D. Langefeld, JoLyn Turner, Marina Núñez, Kevin P. High, Mitzie Spainhour, Andrew A. Hicks, Donald W. Bowden, Amber Reeves‐Daniel, Mariana Murea, Michael V. Rocco, Jasmin Divers	55
6	Apolipoprotein L1 nephropathy risk variants associate with HDL subfraction concentration in African Americans 2011 ·Nephrology Dialysis Transplantation ·Barry I. Freedman, Carl D. Langefeld, Mariana Murea, Lijun Ma, James D. Otvos, JoLyn Turner, Peter A. Antinozzi, Jasmin Divers, Andrew A. Hicks, Donald W. Bowden, Michael V. Rocco, John S. Parks	28
7	Levels of Serum Markers of Liver Inflammation and Fibrosis in Patients with Chronic Hepatitis C Virus Infection According to HIV Status and Antiretroviral Use 2010 ·AIDS Research and Human Retroviruses ·(unknown), JoLyn Turner, Marina Núñez	8
8	Tachpyridine, a metal chelator, induces G2 cell-cycle arrest, activates checkpoint kinases, and sensitizes cells to ionizing radiation 2005 ·Blood ·JoLyn Turner	68
9	Iron Chelators in Cancer Chemotherapy 2004 ·Current Topics in Medicinal Chemistry ·Joan L. Buss, Bryan T. Greene, JoLyn Turner, Frank M. Torti, Suzy V. Torti	165

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact